Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Original Article
A.M. Eggermont, C.U. Blank, M. Mandala, G.V. Long, V. Atkinson, S. Dalle, A. Haydon, M. Lichinitser, A. Khattak, M.S. Carlino, S. Sandhu, J. Larkin, S. Puig, P.A. Ascierto, P. Rutkowski, D. Schadendorf, R. Koornstra, L. Hernandez-Aya, M. Maio, A.J.v.d. Eertwegh, J.-J. Grob, R. Gutzmer, R. Jamal, P. Lorigan, N. Ibrahim, S. Marreaud, A.C.v. Akkooi, S. Suciu, and C. Robert
N Engl J Med 2018;378:1789-1801
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, May 10, 2020 - 11:59pm.